Business · 21/10/2002Updated: 10/17/2026 · 1 min read
Women's Health Initiative Subcommittee of the Advisory Committee for Reproductive Health Drugs to Hold Meeting
Summary
The Women's Health Initiative Subcommittee of the Advisory Committee for Reproductive Health Drugs will hold a meeting, as announced in a notice published on the FDA website (https://www.fda.gov/). The committee will discuss various topics related to reproductive health drugs.